Randomized Study to Evaluate the Impact of Telemedicine Care in Patients With Type 1 Diabetes With Multiple Doses of Insulin and Suboptimal HbA1c in Andalusia (Spain): PLATEDIAN Study
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess the impact of a telemedicine visit using the platform Diabetic compared with a face-to-face visit on clinical outcomes, patients’ health-related quality of life (HRQoL), and physicians’ satisfaction in patients with type 1 diabetes. RESEARCH DESIGN AND METHODS: PLATEDIAN (Telemedicine on Metabolic Control in Type 1 Diabetes Mellitus Andalusian Patients) (NCT03332472) was a multicenter, randomized, 6-month follow-up, open-label, parallel-group controlled study performed in patients with type 1 diabetes with suboptimal metabolic control (HbA1c <8% [<64 mmol/mol]), treated with multiple daily injections. A total of 388 patients were assessed for eligibility; 379 of them were randomized 1:1 to three face-to-face visits (control cohort [CC]) (n = 167) or the replacement of an intermediate face-to-face visit by a telemedicine visit using Diabetic (intervention cohort [IC]) (n = 163). The primary efficacy end point was the mean change of HbA1c levels from baseline to month 6. Other efficacy and safety end points were mean blood glucose, glucose variability, episodes of hypoglycemia and hyperglycemia, patient-reported outcomes, and physicians’ satisfaction. RESULTS: At month 6, the mean change in HbA1c levels was −0.04 ± 0.5% (−0.5 ± 5.8 mmol/mol) in the CC and 0.01 ± 0.6% (0.1 ± 6.0 mmol/mol) in the IC (P = 0.4941). The number of patients who achieved HbA1c <7% (<53 mmol/mol) was 73 and 78 in the CC and IC, respectively. Significant differences were not found regarding safety end points at 6 months. Changes in HRQoL between the first visit and final visit did not differ between cohorts, and, regarding fear of hypoglycemia (FH-15 score ≥28), statistically significant differences observed at baseline remained unchanged at 6 months (P < 0.05). CONCLUSIONS: The use of telemedicine in patients with type 1 diabetes with HbA1c <8% (<64 mmol/mol) provides similar efficacy and safety outcomes as face-to-face visits.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Those persons with lower socioeconomic status have a higher risk for developing T2D, worse DM control, and more DM-related complications.1661–1663”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1662]
Citations
Cites
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Standards of Medical Care in Diabetes 2014
(2014) · Majmaah Journal of Health Sciences · doi:10.12816/0004790 · Cited by 1,465
Introduction: Standards of Medical Care in Diabetes—2018
(2018) · Diabetes Care · doi:10.2337/dc18-sint01 · Cited by 472
Charpentier, G., Benhamou, P.-Y., Dardari, D., Clergeot, A., Franc, S., Schaepelynck-Belicar, P., Catargi, B., Melki, V., Chaillous, L., Farret, A., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1259 · Cited by 292
Faruque, L. I., Wiebe, N., Ehteshami-Afshar, A., Liu, Y., Dianati-Maleki, N., Hemmelgarn, B. R., Manns, B. J., & Tonelli, M. (2017) · Canadian Medical Association Journal · doi:10.1503/cmaj.150885 · Cited by 281
Tchero, H., Kangambega, P., Briatte, C., Brunet-Houdard, S., Retali, G.-R., & Rusch, E. (2019) · Telemedicine and e-Health · doi:10.1089/tmj.2018.0128 · Cited by 239
Telehealthcare for chronic obstructive pulmonary disease
McLean, S., Nurmatov, U., Liu, J. L., Pagliari, C., Car, J., & Sheikh, A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007718.pub2 · Cited by 225
Zhai, Y.-K., Zhu, W.-J., Cai, Y.-L., Sun, D.-X., & Zhao, J. (2014) · Medicine · doi:10.1097/md.0000000000000312 · Cited by 221
Development and Validation of the Diabetes Quality of Life Brief Clinical Inventory
Burroughs, T. E., Desikan, R., Waterman, B. M., Gilin, D., & McGill, J. (2004) · Diabetes Spectrum · doi:10.2337/diaspect.17.1.41 · Cited by 209
Rossi, M. C. E., Nicolucci, A., Di Bartolo, P., Bruttomesso, D., Girelli, A., Ampudia, F. J., Kerr, D., Ceriello, A., Mayor, C. D. L. Q., Pellegrini, F., et al. (2010) · Diabetes Care · doi:10.2337/dc09-1327 · Cited by 174
Research works printed but not linked: 4
- World Health Organization, 2010, Telemedicine: Opportunities and Developments in Member States: Report on the Second Global Survey on eHealth 2009
- European Medicines Agency, 2016, Guideline for Good Clinical Practice E6(R2), 1
- Ruiz de Adana, 2012, High inflammatory markers in subjects with type 1 diabetes and its relationship with diabetes-related complications and insulin treatment, Av Diabetol, 28, 1
- StataCorp, 2015, Stata Statistical Software: Release 14
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Grunberger, G., Sherr, J., Allende, M., Blevins, T., Bode, B., Handelsman, Y., Hellman, R., Lajara, R., Roberts, V. L., Rodbard, D., et al. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.04.008 · Cited by 288
Adoption of Telemedicine for Type 1 Diabetes Care During the COVID-19 Pandemic
Lee, J. M., Carlson, E., Albanese-O'Neill, A., Demeterco-Berggren, C., Corathers, S. D., Vendrame, F., Weinstock, R. S., Prahalad, P., Alonso, G. T., Kamboj, M., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0080 · Cited by 77
Ahmadiankalati, M., Steins-Loeber, S., & Paslakis, G. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00568 · Cited by 56
Physician Satisfaction With Telehealth: A Systematic Review and Agenda for Future Research
Hoff, T., & Lee, D.-R. (2022) · Quality Management in Health Care · doi:10.1097/qmh.0000000000000359 · Cited by 61
Pal, R., Yadav, U., Verma, A., & Bhadada, S. K. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.07.001 · Cited by 50
Konnyu, K. J., Yogasingam, S., Lépine, J., Sullivan, K., Alabousi, M., Edwards, A., Hillmer, M., Karunananthan, S., Lavis, J. N., Linklater, S., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014513 · Cited by 37
von Sengbusch, S., Eisemann, N., Müller–Godeffroy, E., Lange, K., Dördelmann, J., Erdem, A., Menrath, I., Bokelmann, J., Krasmann, M., Kaczmarczyk, P., et al. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13133 · Cited by 45
“In this 6-month intervention, no difference was found in the two adult cohorts.(18) In contrast, a German study observed lower scores in some domains of the HRQOL instrument KidsCAT in children and youths with HbA1c > 9%.”
ResultZhang, K., Huang, Q., Wang, Q., Li, C., Zheng, Q., Li, Z., Xu, D., Xie, C., Zhang, M., & Lin, R. (2024) · Journal of Medical Internet Research · doi:10.2196/51538 · Cited by 54
“…focus on (1) telemonitoring (eg, a web-based telemedicine system was used to monitor patients with T1DM in the study by Ruiz de Adana et al [15]), (2) tele-education (eg, Molavynejad et al [16] delivered tele-education to patients with diabetes using remote video-based technology), and (3)…”
Laurberg, T., Schougaard, L. M. V., Hjøllund, N. H., Lomborg, K. E., Hansen, T. K., & Jensen, A. L. (2022) · Diabetic Medicine · doi:10.1111/dme.14791 · Cited by 31
Andino, J. J., Eyrich, N. W., & Boxer, R. J. (2023) · mHealth · doi:10.21037/mhealth-23-15 · Cited by 35
Kompala, T., & Neinstein, A. B. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000600 · Cited by 32
The Value of Physical Examination in the Era of Telemedicine
Lee, P. S., Koo, S., & Panter, S. (2021) · Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2021.122 · Cited by 29
Turnin, M.-C., Gourdy, P., Martini, J., Buisson, J.-C., Chauchard, M.-C., Delaunay, J., Schirr-Bonnans, S., Taoui, S., Poncet, M.-F., Cosma, V., et al. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01095-x · Cited by 20
Gaudillère, M., Pollin-Javon, C., Brunot, S., Fimbel, S., & Thivolet, C. H. (2021) · Diabetes & Metabolism · doi:10.1016/j.diabet.2021.101251 · Cited by 21
Yu, X., Wang, Y., Liu, Z., & Jung, E. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1549568 · Cited by 36
Patient Satisfaction with Telemedicine in Adults with Diabetes: A Systematic Review
Hamasaki, H. (2022) · Healthcare · doi:10.3390/healthcare10091677 · Cited by 21
Could Online Education Replace Face-to-Face Education in Diabetes? A Systematic Review
Alonso-Carril, N., Rodriguez-Rodríguez, S., Quirós, C., Berrocal, B., Amor, A. J., Barahona, M. J., Martínez, D., Ferré, C., & Perea, V. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01595-6 · Cited by 21
Pérez, C. T., Moreno, Ó., Ríos, J., & Reyes‐García, R. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108547 · Cited by 20
Jensen, A. L., Schougaard, L. M. V., Laurberg, T., Hansen, T. K., & Lomborg, K. E. (2023) · Scandinavian Journal of Caring Sciences · doi:10.1111/scs.13154 · Cited by 21
Ballesta, S., Chillarón, J. J., Inglada, Y., Climent, E., Llauradó, G., Pedro‐Botet, J., Cots, F., Camell, H., Roux, J. A. F., & Benaiges, D. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1176765 · Cited by 17
Bassi, M., Scalas, M., Spacco, G., Perasso, V., Franzone, D., Strati, M. F., Dufour, F., Lionetti, B., Rizza, F., Parodi, S., et al. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1228975 · Cited by 20
Salabelle, C., Ly Sall, K., Eroukhmanoff, J., Franc, S., Oumbiche, H., Zrafi, W. S., Dang Duy, T. L., Valentim, C., Gaston, F., Fernandes, S., et al. (2021) · Primary Care Diabetes · doi:10.1016/j.pcd.2021.06.013 · Cited by 14
Telemedicine for the management of diabetic patients in a high-complexity Latin American hospital
Casas, L. Á., Alarcón, J., Urbano, A., Peña-Zárate, E. E., Sangiovanni, S., Libreros‐Peña, L., & Escobar, M. F. (2023) · BMC Health Services Research · doi:10.1186/s12913-023-09267-0 · Cited by 20
“Clinical trials comparing telemedicine with in-person care did not report an increase in the number of cases of hypoglycemia reported by patients [22, 30], but telemedicine does not seem to have a protective effect against hypoglycemic episodes [27].”
BackgroundEberle, C., & Stichling, S. (2021) · JMIR Diabetes · doi:10.2196/20270 · Cited by 17
Kaushal, T., TINSLEY, L. J., Volkening, L. K., Turcotte, C., & Laffel, L. M. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac476 · Cited by 16
Inpatient Diabetes Management During the COVID-19 Crisis: Experiences From Two Community Hospitals
Shelton, C., Demidowich, A. P., & Zilbermint, M. F. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820930268 · Cited by 11
Using digital tools to improve diabetes care in India with continuous glucose monitoring
Kesavadev, J., Saboo, B., Chawla, M. S., Unnikrishnan, A., Dunn, T. C., & TIWASKAR, M. H. (2025) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188251372290 · Cited by 8
“58,59 Physician endorsement and personalized tele-medicine methods greatly influence patients’ decisions to use telemedicine.”
Metrics for Evaluating Telemedicine in Randomized Controlled Trials: Scoping Review
Sugawara, Y., Hirakawa, Y., Iwagami, M., Inokuchi, R., Wakimizu, R., & Nangaku, M. (2025) · Journal of Medical Internet Research · doi:10.2196/67929 · Cited by 8
Digital management of diabetes global research trends: a bibliometric study
Zhu, S., Bian, H., Zhan, J., Ni, L., Huo, L., & Hu, J. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1620307 · Cited by 7
Evaluation of telehealth support in an integrated respiratory clinic
Fox, L., Heiden, E., Chauhan, M., Longstaff, J., Balls, L., Vos, R. D., Neville, D. M., Jones, T. L., Leung, A. W., Morrison, L., et al. (2022) · npj Primary Care Respiratory Medicine · doi:10.1038/s41533-022-00304-9 · Cited by 6
Plachý, L., Neuman, V., Velichova, K., Slavenko, M. G., Šantová, A., Amaratunga, S. A., Obermannová, B., Koloušková, S., Průhová, Š., Šumník, Z., et al. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111602 · Cited by 5
Fogliazza, F., Sambati, V., Iovane, B., Lazzeroni, P., Street, M. E., & Esposito, S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237359 · Cited by 8
Consenso Delphi sobre el uso de la telemedicina en reumatología: estudio RESULTAR
Gil, J. G., Moreno, M. J., & Cubero, M. D. C. C. (2024) · Reumatología Clínica · doi:10.1016/j.reuma.2024.01.005 · Cited by 4
Schultz, A. N. Ø., Christensen, R., Bollig, G., Kidholm, K., & Brandt, F. (2025) · Diabetologia · doi:10.1007/s00125-025-06585-2 · Cited by 3
“This attrition percentage is similar to that in previous studies [3, 8].”
Bassi, M., Dufour, F., Strati, M. F., Franzone, D., Scalas, M., Lionetti, B., Spacco, G., Rizza, F., Sburlati, P., Casalini, E., et al. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1249299 · Cited by 3
Delphi consensus on the use of telemedicine in rheumatology: RESULTAR study
Gil, J. G., Moreno, M. J., & Cubero, M. D. C. C. (2024) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2024.05.005 · Cited by 5
Meyer, L., Flocard, M., Fabacher, T., Bahougne, T., Ortéga, F., Paris, D., Munch, M., Boullu-Sanchis, S., Canel, C., Chappaz, C., et al. (2022) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2022.0090 · Cited by 3
Schultz, A. N. Ø., Christensen, R., Bollig, G., Kidholm, K., & Brandt, F. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-058728 · Cited by 2
de Adana, M. S. R., Domínguez, M., Morillas, V., Colomo, N., Mora, M. R. V., Guerrero, M., García‐Escobar, E., Carreira, M., Romero‐Zerbo, S., Linares, F., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110238 · Cited by 3
Self-citationMontesinos, S. P., Morano, C., & Díez, L.-R. (2022) · Primary care diabetes · doi:10.1016/j.pcd.2022.03.011 · Cited by 2
Frigola, I. B., Coca-Villalba, F., Pérez-Lacasta, M. J., & Lavila, M. C. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1033461 · Cited by 1
Romeo, G. R., Bennetti, M., VOTTA, J. L., Gibson, C., Gatti, S., & Toschi, E. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.11.005 · Cited by 3
Fernández‐Rodrigo, M. T., del Hoyo, M. L. L., Urcola‐Pardo, F., Subirón‐Valera, A. B., Rodríguez‐Roca, B., Ruiz, D. C. G., Borao, M. M. G., Funcia, M. T. A., Alcázar, A. B. A., & Roy‐Delgado, J. F. (2024) · Worldviews on Evidence-Based Nursing · doi:10.1111/wvn.12744 · Cited by 3
MHEALTH: Ferramenta educativa eficaz para controle glicêmico em pacientes diabéticos?
Batista, E. M. M., & Rendeiro, M. M. P. (2021) · RENOTE · doi:10.22456/1679-1916.118535
Abebe, H., Chiwewe, S., Astermark, C., Sandberg, M., & Tiberg, I. (2023) · Research Square · doi:10.21203/rs.3.rs-2630982/v1 · Cited by 1
La pandemia de COVID-19 ha impulsado el manejo de la diabetes vía telemedicina
Márquez-Rodríguez, E., Madrigal-Sanromán, J. R., de la Maza-Viadero, M. E. S., & Faradji-Hazan, R. N. (2020) · Revista Mexicana de Endocrinología Metabolismo y Nutrición · doi:10.24875/rme.20000038 · Cited by 1
Iklé, J. M., Addala, A., & Maahs, D. M. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch69
Restrepo, J. M. R., Pérez, I. R., García‐Luna, P. P., Cunill, J. L. P., López, F. J. V., Marín, M. G., Yeste-Doblas, C., Martínez-Ortega, A. J., Martínez-Ramírez, M. J., Morell, C. L., et al. (2024) · Nutrición Hospitalaria · doi:10.20960/nh.04702
Güngör, A., & Bükülmez, A. (2024) · Kocatepe tıp dergisi. · doi:10.18229/kocatepetip.1375129
Sharma, S. (2024) · Queensland University of Technology · doi:10.5204/thesis.eprints.251462
Assessing the Impact of Telemedicine on Healthcare Management and Delivery in Rural Areas
Sahoo, L. K., Hasan, F., & RenukaJyothi, S. (2022) · Health Leadership and Quality of Life · doi:10.56294/hl2022114
Metadata
- Authors
- Ruiz de Adana, M. S., Alhambra-Expósito, M. R., Muñoz-Garach, A., Gonzalez-Molero, I., Colomo, N., Torres-Barea, I., Aguilar-Diosdado, M., Carral, F., Serrano, M., Martínez-Brocca, M. A., Duran, A., & Palomares, R.
- Affiliations
- Endocrinology and Nutrition Department, Hospital Regional Universitario de Málaga, Málaga, Spain
- Endocrinology and Nutrition Department, Hospital Universitario Reina Sofía, Córdoba, Spain
- Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES)
- Hospital Universitario de Jerez (ES)
- Endocrinology and Nutrition Department, Hospital Universitario Puerta del Mar, Cádiz, Spain
- Hospital Universitario Puerto Real (ES)
- Complejo Hospitalario de Jaén (ES)
- Endocrinology and Nutrition Department, Hospital Universitario Virgen Macarena, Sevilla, Spain
- Sanofi (Spain) (ES)
- Instituto Maimónides de Investigación Biomédica de Córdoba (ES)
- Corresponding author
- Colomo, Natalia
- ORCID
- Colomo, Natalia
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2019-12-12
- Volume
- 43
- Issue
- 2
- Pages
- 337-342
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2996438223
- Cited by
- 53
- References
- 25
- Citations by year
- 2025: 5 · 2024: 13 · 2023: 10 · 2022: 10 · 2021: 8 · 2020: 7
- FWCI
- 5.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- RISalud Institutional Health Repository of Andalucía (submittedVersion)
- Funders
- Andalusian Society of Endocrinology, Diabetes, and Nutrition
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- telemedicine, HbA1c, glycemic control, multiple daily insulin injections, health-related quality of life, fear of hypoglycemia, hypoglycemia, glycemic variability, physician satisfaction, Andalusia, patient-reported outcomes
- MeSH terms
- Adult, Blood Glucose, Diabetes Mellitus, Type 1, Dose-Response Relationship, Drug, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Injections, Insulin, Male, Middle Aged, Office Visits, Primary Health Care, Quality of Life, Spain, Treatment Outcome, Telemedicine, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.